Showing results (161-170 of 576) with videos related to
Sort By:
Pageof 58
International Journal of Tissue Reactions|January 1, 1991
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteinsW O Richter, B G Jacob, P SchwandtArtificial Organs|April 1, 1996
Short- and long-term effects on serum lipoproteins by three different techniques of apheresisW O Richter, M G Donner, P SchwandtArchives of Physical Medicine and Rehabilitation|June 8, 2014
Effects of Feldenkrais method on chronic neck/scapular pain in people with visual impairment: a randomized controlled trial with one-year follow-upLars-Olov Lundqvist, Christina Zetterlund, Hans O RichterRespiration; International Review of Thoracic Diseases|January 1, 1984
The dyskinetic cilia syndrome in childhood. Modifications of ultrastructural patternsB Becker, K Morgenroth, D Reinhardt, et al.Klinische Padiatrie|June 5, 2003
[Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93]U Creutzig, M Zimmermann, D Reinhardt, et al.The European Respiratory Journal|October 6, 1997
Nebulization of a bovine surfactant in cystic fibrosis: a pilot studyM Griese, P Bufler, J Teller, et al.Artificial Organs|March 7, 2002
RheoSorb: a specific adsorber for fibrinogen elimination in clinical situations with impaired rheologyR A Koll, J Klinkmann, W O RichterJournal of Cardiovascular Pharmacology|September 1, 1993
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemiaB G Jacob, W O Richter, P SchwandtThe Clinical Investigator|November 1, 1993
Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapyB G Jacob, W O Richter, P SchwandtFortschritte Der Medizin|July 20, 1997
[Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?]M G Donner, P Schwandt, W O RichterPageof 58